ReviewToxins2020
Forty Years of the Description of Brown Spider Venom Phospholipases-D.
Review in Toxins, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 58 citations in OpenAlex.
- Spider venom phospholipase D toxin structure: Interfacial binding site, mechanism, activation, and head group preference.Proceedings of the National Academy of Sciences of the United States of America · 2026Article
- Proteome Analysis of the Six-Eyed Sand-SpiderToxins · 2025Article
- The Adjuvant Effect of Hyperbaric Oxygenation forMetabolites · 2025Article
- Article
- Review
- Hemoadsorption in Multiorgan Failure Due to Viscerocutaneous Loxoscelism.Medicina (Kaunas, Lithuania) · 2025Article
- Enlightening the toxinological dark matter of spider venom enzymes.npj biodiversity · 2024Article
- Venom Ex Machina? Exploring the Potential of Cell-Free Protein Production for Venom Biodiscovery.International journal of molecular sciences · 2024Article
- Binding of green tea epigallocatechin gallate to the arginine kinase active site from the brown recluse spider (Heliyon · 2024Article
- A Brief Overview of the Toxic Sphingomyelinase Ds of Brown Recluse Spider Venom and Other Organisms and Simple Methods To Detect Production of Its Signature Cyclic Ceramide Phosphate.Molecular pharmacology · 2024Article
- The Health Status of Horses Used for at Least Six Complete Cycles of Loxoscelic Antivenom Production.Toxins · 2023Article
- Comparative Biochemical, Structural, and Functional Analysis of Recombinant Phospholipases D from ThreeInternational journal of molecular sciences · 2023Article
- Massive dermal ulcerative lesions because of brown recluse spider bite: a rare case report and review of literature.Journal of surgical case reports · 2023Article
- Production and Functional Evaluation of Anti-Biomedicines · 2022Article
- Review
- Brown spider (Loxosceles sp.) bite and COVID-19: A case report.Toxicon : official journal of the International Society on Toxinology · 2022Article
- Clinical Effects of the Immunization Protocol UsingToxins · 2022Article
- The Enzymatic Core of Scorpion Venoms.Toxins · 2022Article
- Protective Effectiveness of an Immunization Protocol Against the Toxic Effects ofFrontiers in veterinary science · 2022Article
- A Case Report of Brown Recluse Spider Bite.Cureus · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 3 institutions in 1 country.
Funding
Abstract
Spiders of the genus
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.